Web Desc
HIV Vaccines: Current Challenges and Future Prospects
joint with HIV Pathogenesis
Organizer(s): David C. Montefiori, Kent J. Weinhold and Carolyn Williamson
Date: April 09 - 15, 2005
Location: Fairmont Banff Springs, Banff, AB, Canada
Part of the Global Health Series, Supported by the Bill & Melinda Gates Foundation, and Sponsored by Wyeth Vaccines Research
For important information on the coronavirus, please click here
Summary of Meeting:
The need to develop a vaccine for AIDS has never been so urgent. The number of people infected with HIV has grown to over 40 million and continues to increase at an alarming rate in many developing countries. The disappointing results of AIDSVAX, the first candidate HIV vaccine to be tested in phase III efficacy trials, underscore the need for heightened efforts. A variety of candidate HIV vaccines are tested in animal models and phase I/II clinical trials every year, yielding new information on safety, immunogenicity and potential efficacy. Moreover, considerable efforts are underway to gain a better understanding of the genetic diversity and antigenic structure of the virus, the immune responses that contain HIV infection, and the complex mechanisms used by the virus to evade those immune responses. Investigators hope to use this collective information to engineer improved immunogens. This Keystone Symposium aims to address the scientific obstacles to vaccine development, to identify promising leads that may help overcome those obstacles, to foster open scientific discussions of the most recent unpublished results from pre-clinical and clinical trials and to forge new collaborations that will accelerate the development of a safe and effective HIV vaccine.
Discounted Abstract Deadline: December 9 2004
Discounted Registration Deadline: February 10 2005
We gratefully acknowledge additional support for this conference from:
Bill & Melinda Gates FoundationOffice of AIDS Research, NIHWyeth Vaccines Research
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Merck Research Laboratories

Wyeth Research Labs
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13-AI063798-01
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

Program

Saturday, April 09 | 3:00PM - 7:30PM
Registration
Room: Van Horne Ballroom Foyer


Saturday, April 09 | 6:30PM - 7:30PM
Refreshments
Room: Van Horne Ballroom Foyer


Saturday, April 09 | 7:30PM - 9:30PM
Keynote Address (Joint)
Room: Van Horne Ballroom

Speaker 1 of 2
Douglas D. Richman, University of California, San Diego, USA
HIV Pathogenesis: Twenty Years of Successes and Failures

Saturday, April 09 | 7:30PM - 9:30PM
Keynote Address (Joint)
Room: Van Horne Ballroom

Speaker 2 of 2
José G. Esparza, Bill & Melinda Gates Foundation, USA
Harnessing Science and Policy to Accelerate HIV Vaccine Development

Sunday, April 10 | 7:00AM - 8:00AM
Breakfast
Room: New Brunswick, Alberta, Cascade


Sunday, April 10 | 8:00AM - 11:20AM
Viral Diversity
Room: Van Horne Ballroom C

Speaker 1 of 7
* Carolyn Williamson, University of Cape Town, South Africa
Genetic Heterogeneity of Subtype C HIV-1 Infection in Africa

Sunday, April 10 | 8:00AM - 11:20AM
Viral Diversity
Room: Van Horne Ballroom C

Speaker 2 of 7
Francine McCutchan, PATH, USA
Screening for HIV-1 Dual Infection in Populations Exposed to Multiple Subtypes

Sunday, April 10 | 8:00AM - 11:20AM
Viral Diversity
Room: Van Horne Ballroom C

Speaker 3 of 7
Bette Tina Marie Korber, Los Alamos National Laboratory, USA
Understanding and Explaining the Limitations of HIV Evolution

Sunday, April 10 | 8:00AM - 11:20AM
Viral Diversity
Room: Van Horne Ballroom C

Speaker 4 of 7
James I. Mullins, University of Washington, USA
HIV Evolution in Forward and Reverse

Sunday, April 10 | 8:00AM - 11:20AM
Viral Diversity
Room: Van Horne Ballroom C

Speaker 5 of 7
Chunfu Yang, Centers for Disease Control, USA
Short Talk: Genetic Diversification and Recombination of HIV-1 Group M in Kinshasa, Democratic Republic of Congo

Sunday, April 10 | 8:00AM - 11:20AM
Viral Diversity
Room: Van Horne Ballroom C

Speaker 6 of 7
Wendy M. Blay, Seattle Biomedical Research Institute, USA
Short Talk: Convergent Patterns of Change in Potential N-Linked Glycosylation (PNG) Sites of SHIV89.6p

Sunday, April 10 | 8:00AM - 11:20AM
Viral Diversity
Room: Van Horne Ballroom C

Speaker 7 of 7
Terri Wrin, Monogram Biosciences, USA
Short Talk: Evolution of HIV-1 Envelope and Antibody Neutralization Activity in Identical Twins and a Sibling Infected with the Same Virus

Sunday, April 10 | 8:00AM - 11:00AM
Transmission
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 1 of 6
* John P. Moore, Weill Medical College of Cornell University, USA


Sunday, April 10 | 8:00AM - 11:00AM
Transmission
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 2 of 6
Ashley T. Haase, University of Minnesota, USA
The Fast Phase of Slow Lentiviral Infection


Sunday, April 10 | 8:00AM - 11:00AM
Transmission
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 3 of 6
Susan A. Allen, Emory University School of Public Health, USA
Couples' HIV Counseling and Testing in basic science research and public health


Sunday, April 10 | 8:00AM - 11:00AM
Transmission
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 4 of 6
Yvette van Kooyk, Vrije University Medical Center, Netherlands
Viruses Use Carbohydrates to Escape Immunity Induced by Dendritic Cells


Sunday, April 10 | 8:00AM - 11:00AM
Transmission
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 5 of 6
Andrew Blauvelt, Oregon Health & Science University, USA
CCR5-Mediated HIV Infection of Langerhans Cells


Sunday, April 10 | 8:00AM - 11:00AM
Transmission
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 6 of 6
Clare Jolly, University College London, UK
Short Talk: Cell to Cell Spread of HIV-1 Across a Virological Synapse


Sunday, April 10 | 9:20AM - 9:40AM
Coffee Break
Room: Van Horne Ballroom Foyer


Sunday, April 10 | 11:20AM - 1:00PM
Poster Setup
Room: New Brunswick, Alberta, Cascade


Sunday, April 10 | 1:00PM - 10:00PM
Poster Viewing
Room: New Brunswick, Alberta, Cascade


Sunday, April 10 | 2:30PM - 4:30PM
Workshop 1: Intracellular Interactions
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 1 of 7
* Greg J. Towers, University College London, UK


Sunday, April 10 | 2:30PM - 4:30PM
Workshop 1: Intracellular Interactions
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 2 of 7
Vincent Piguet, Cardiff University, UK
Trafficking of HIV-1 to the Dendritic Cell-T cell Infectious Synapse Uses DC-SIGN and the Pathway of Tetraspanin Sorting to the Immunological Synapse


Sunday, April 10 | 2:30PM - 4:30PM
Workshop 1: Intracellular Interactions
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 3 of 7
Mark E. Sharkey, Miller School of Medicine, University of Miami, USA
Stable Sequestration and Dissemination in Trans of Intracellular Virions by HIV-1 Infected Macrophages


Sunday, April 10 | 2:30PM - 4:30PM
Workshop 1: Intracellular Interactions
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 4 of 7
Mojgan H. Naghavi, Centre for Research in Infectious Diseases, University College Dublin, Ireland
Overexpression of Fasciculation and Elongation Protein zeta-1 (FEZ1) Induces a Postentry Block to Retroviruses in Cultured Cells


Sunday, April 10 | 2:30PM - 4:30PM
Workshop 1: Intracellular Interactions
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 5 of 7
Philippe Gallay, The Scripps Research Institute, USA
Interplay Between HIV-1 Capsid, Cyclophilin A and Primate Restriction


Sunday, April 10 | 2:30PM - 4:30PM
Workshop 1: Intracellular Interactions
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 6 of 7
Thomas J. Hope, Northwestern University, USA
Cell Biology of TRIM5alpha


Sunday, April 10 | 2:30PM - 4:30PM
Workshop 1: Intracellular Interactions
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 7 of 7
Eric Poeschla, University of Colorado School of Medicine, USA
Identification of the LEDGF/p75 HIV-1 Integrase-Interaction Domain and NLS Reveals NLS-Independent Chromatin Tethering


Sunday, April 10 | 4:30PM - 5:00PM
Coffee & Snacks Available
Room: Van Horne Ballroom Foyer


Sunday, April 10 | 5:00PM - 7:15PM
Transmission and Immune Escape
Room: Van Horne Ballroom C

Speaker 1 of 6
* David I. Watkins, University of Miami, USA
CD8+ Responses in LTNP and Vaccinated Macaques


Sunday, April 10 | 5:00PM - 7:15PM
Transmission and Immune Escape
Room: Van Horne Ballroom C

Speaker 2 of 6
Eric Hunter, Emory University, USA
Env Determinants that Influence Neutralization Sensitivity - Lessons from Transmission Pairs

Sunday, April 10 | 5:00PM - 7:15PM
Transmission and Immune Escape
Room: Van Horne Ballroom C

Speaker 3 of 6
Georgia D. Tomaras, Duke University Medical Center, USA
Immune Escape in HIV-1 Infection

Sunday, April 10 | 5:00PM - 7:15PM
Transmission and Immune Escape
Room: Van Horne Ballroom C

Speaker 4 of 6
Catherine A. Blish, Stanford University School of Medicine, USA
Short Talk: Susceptibility of Recently Transmitted HIV-1 Variants to Neutralization by Autologous and Heterologous Plasma

Sunday, April 10 | 5:00PM - 7:15PM
Transmission and Immune Escape
Room: Van Horne Ballroom C

Speaker 5 of 6
Jesus F. Salazar-Gonzalez, University of Alabama at Birmingham, USA
Short Talk: HIV-1 Quasispecies Complexity in Acute and Early Infection

Sunday, April 10 | 5:00PM - 7:15PM
Transmission and Immune Escape
Room: Van Horne Ballroom C

Speaker 6 of 6
Marcus Altfeld, Heinrich-Pette-Institute, Germany
Short Talk: De-Novo Generation of HIV-1-Specific CD8+ T Cell Responses Directed Against CTL Escape Variants

Sunday, April 10 | 5:00PM - 7:15PM
Virus and Cells: The Way In
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 1 of 5
* Thomas J. Hope, Northwestern University, USA


Sunday, April 10 | 5:00PM - 7:15PM
Virus and Cells: The Way In
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 2 of 5
Robert W. Doms, University of Pennsylvania School of Medicine, USA
HIV Entry and its Inhibition


Sunday, April 10 | 5:00PM - 7:15PM
Virus and Cells: The Way In
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 3 of 5
Judy Lieberman, Harvard University, USA
Use of Small Interfering RNAs to Block Transmission of HIV and Other Sexually Transmitted Diseases


Sunday, April 10 | 5:00PM - 7:15PM
Virus and Cells: The Way In
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 4 of 5
Stuart F.J. Le Grice, NCI, National Institutes of Health, USA
Reverse Transcription – A New Look at an Old Adversary


Sunday, April 10 | 5:00PM - 7:15PM
Virus and Cells: The Way In
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 5 of 5
Frederic D. Bushman, University of Pennsylvania, USA
Targeting of HIV DNA Integration to Transcription Units: Tethering via a Human Transcription Factor


Sunday, April 10 | 7:15PM - 8:15PM
Social Hour
Room: New Brunswick, Alberta, Cascade


Sunday, April 10 | 7:30PM - 10:00PM
Poster Session 1
Room: New Brunswick, Alberta, Cascade


Monday, April 11 | 7:00AM - 8:00AM
Breakfast
Room: New Brunswick, Alberta, Cascade


Monday, April 11 | 8:00AM - 11:00AM
Protective Immunity I: Neutralizing Antibodies (Joint)
Room: Van Horne Ballroom

Speaker 1 of 6
* Lynn Morris, National Institute for Communicable Diseases, South Africa
Neutralizing Antibody Responses to Subtype C HIV-1 Infection in Africa

Monday, April 11 | 8:00AM - 11:00AM
Protective Immunity I: Neutralizing Antibodies (Joint)
Room: Van Horne Ballroom

Speaker 2 of 6
John R. Mascola, NIAID, National Institutes of Health, USA
Evaluating the Neutralizing Antibody Response Elicited by DNA and Recombinant Adenoviral Vaccines

Monday, April 11 | 8:00AM - 11:00AM
Protective Immunity I: Neutralizing Antibodies (Joint)
Room: Van Horne Ballroom

Speaker 3 of 6
Dennis R. Burton, The Scripps Research Institute, USA
Envelope on the Surface on HIV is Heterogeneous

Monday, April 11 | 8:00AM - 11:00AM
Protective Immunity I: Neutralizing Antibodies (Joint)
Room: Van Horne Ballroom

Speaker 4 of 6
George M. Shaw, University of Pennsylvania, USA
Antigenic Conservation and Immunogenicity of the Co-Receptor Binding Site and Membrane-Proximal External Region (MPER) of HIV-1 and HIV-2

Monday, April 11 | 8:00AM - 11:00AM
Protective Immunity I: Neutralizing Antibodies (Joint)
Room: Van Horne Ballroom

Speaker 5 of 6
Bing Chen, Children's Hospital Boston, USA
Short Talk: Structure of an Unliganded Simian Immunodeficiency Virus gp120 Core

Monday, April 11 | 8:00AM - 11:00AM
Protective Immunity I: Neutralizing Antibodies (Joint)
Room: Van Horne Ballroom

Speaker 6 of 6
Ping Zhu, Florida State University, USA
Short Talk: Cryo-Electron Microscopy of Envelope Spikes on SIV Surfaces

Monday, April 11 | 9:20AM - 9:40AM
Coffee Break
Room: Van Horne Ballroom Foyer


Monday, April 11 | 11:15AM - 1:00PM
Poster Setup
Room: New Brunswick, Alberta, Cascade


Monday, April 11 | 1:00PM - 10:00PM
Poster Viewing
Room: New Brunswick, Alberta, Cascade


Monday, April 11 | 2:30PM - 4:30PM
Workshop 1: Immune Reconstitution and Augmentation
Room: Van Horne Ballroom C

Speaker 1 of 6
* Genoveffa Franchini, NCI, National Institutes of Health, USA
Testing Rational Approaches for Immune Therapy for HIV-1-Infected Individuals in the SIVmac251 Model

Monday, April 11 | 2:30PM - 4:30PM
Workshop 1: Immune Reconstitution and Augmentation
Room: Van Horne Ballroom C

Speaker 2 of 6
Thomas Lehner, Guy's, King's & St. Thomas' Hospital Medical and Dental School, UK
A Novel Therapeutic Immunization Strategy Against HIV

Monday, April 11 | 2:30PM - 4:30PM
Workshop 1: Immune Reconstitution and Augmentation
Room: Van Horne Ballroom C

Speaker 3 of 6
Kevin N. Brown, University of Pittsburgh, USA
Short Talk: Disproportionate Loss of CD11c+ Lymph Node Dendritic Cells in AIDS Associated with Failed Langerhans Cell Migration is Overridden by Injection of Mature Monocyte-Derived Dendritic Cells

Monday, April 11 | 2:30PM - 4:30PM
Workshop 1: Immune Reconstitution and Augmentation
Room: Van Horne Ballroom C

Speaker 4 of 6
Moiz Kitabwalla, Lipid Sciences, Inc., USA
Short Talk: Delipidated Retroviruses as Potential Autologous Therapeutic Vaccines—A Pilot Experiment

Monday, April 11 | 2:30PM - 4:30PM
Workshop 1: Immune Reconstitution and Augmentation
Room: Van Horne Ballroom C

Speaker 5 of 6
Jean D. Boyer, University of Pennsylvania, USA
Short Talk: Dramatic Induction of Antigen Specific Immune Responses and Effects on Viral Rebound Analyzed in a Novel Chronic SIV Infection Treatment Modely by Optimized SIV DNA Antigens + IL-12 Adjuvant Vaccine

Monday, April 11 | 2:30PM - 4:30PM
Workshop 1: Immune Reconstitution and Augmentation
Room: Van Horne Ballroom C

Speaker 6 of 6
Barbara K. Felber, NCI, National Institutes of Health, USA
Short Talk: Control of Viremia after Antiretroviral Treatment and Therapeutic Vaccination with Novel forms of DNA Vaccines in Chronically SIVmac251-Infected Macaque

Monday, April 11 | 4:30PM - 5:00PM
Coffee & Snacks Available
Room: Van Horne Ballroom Foyer


Monday, April 11 | 5:00PM - 7:15PM
Protective Immunity II: Cellular Responses
Room: Van Horne Ballroom C

Speaker 1 of 4
* Kent J. Weinhold, Duke University Medical Center, USA
Immunologic Hallmarks of Early Acute HIV-1 Infection in a Clade B Heterosexual Transmission Cohort - Insights for Vaccine Development

Monday, April 11 | 5:00PM - 7:15PM
Protective Immunity II: Cellular Responses
Room: Van Horne Ballroom C

Speaker 2 of 4
Clive M. Gray, National Institute for Communicable Diseases, South Africa
CD8+ T Responses Associated with Control of HIV-1 Subtype C Infections

Monday, April 11 | 5:00PM - 7:15PM
Protective Immunity II: Cellular Responses
Room: Van Horne Ballroom C

Speaker 3 of 4
Mark Connors, NIAID, National Institutes of Health, USA
Qualitative Features of an Effective HIV-Specific CD8+ T Cell Response

Monday, April 11 | 5:00PM - 7:15PM
Protective Immunity II: Cellular Responses
Room: Van Horne Ballroom C

Speaker 4 of 4
Bali Pulendran, Stanford University School of Medicine, USA
Modulating Vaccine Responses with Dendritic Cells and Pathogen Recognition Receptors

Monday, April 11 | 5:00PM - 7:00PM
Virus and Cells: The Way Out
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 1 of 5
* Mario Stevenson, University of Miami, Leonard M. Miller School of Medicine, USA


Monday, April 11 | 5:00PM - 7:00PM
Virus and Cells: The Way Out
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 2 of 5
Jaisri R. Lingappa, University of Washington, USA
HIV-1 Capsid Assembly Intermediates: Biochemical Sites for Regulation of Anti-Viral Factors and Virus Production Kinetics


Monday, April 11 | 5:00PM - 7:00PM
Virus and Cells: The Way Out
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 3 of 5
Ben Berkhout, University of Amsterdam, Academic Medical Center, Netherlands
HIV-1 Can Evade RNAi-Mediated Inhibition by Altering the Secondary Structure of its RNA Genome


Monday, April 11 | 5:00PM - 7:00PM
Virus and Cells: The Way Out
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 4 of 5
Wesley I. Sundquist, University of Utah School of Medicine, USA
HIV-1 Budding


Monday, April 11 | 5:00PM - 7:00PM
Virus and Cells: The Way Out
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 5 of 5
Elena Chertova, NCI, National Institutes of Health, USA
Short Talk: Proteomic and Biochemical Analysis of HIV-1 Produced from Human Monocyte-Derived Macrophages


Monday, April 11 | 7:00PM - 8:00PM
Social Hour
Room: New Brunswick, Alberta, Cascade


Monday, April 11 | 7:30PM - 10:00PM
Poster Session 2
Room: New Brunswick, Alberta, Cascade


Tuesday, April 12 | 7:00AM - 8:00AM
Breakfast
Room: New Brunswick, Alberta, Cascade


Tuesday, April 12 | 8:00AM - 11:00AM
Novel Immunogens and Vaccine Concepts I
Room: Van Horne Ballroom C

Speaker 1 of 6
* Stephen A. Udem, Wyeth Pharmaceuticals, USA
Next Generation pDNA and Recombinant VSV Vectored Vaccines for Immunization Against HIV

Tuesday, April 12 | 8:00AM - 11:00AM
Novel Immunogens and Vaccine Concepts I
Room: Van Horne Ballroom C

Speaker 2 of 6
Richard T. Wyatt, IAVI Neutralizing Antibody Center, The Scripps Research Institute, USA
Analysis of HIV-1 Envelope Glycoproteins for Immunogen Design to Elicit Broadly Neutralizing Antibodies

Tuesday, April 12 | 8:00AM - 11:00AM
Novel Immunogens and Vaccine Concepts I
Room: Van Horne Ballroom C

Speaker 3 of 6
Feng Gao, Duke University Medical Center, USA
Immunogenicity of Consensus Envelope Immunogens

Tuesday, April 12 | 8:00AM - 11:00AM
Novel Immunogens and Vaccine Concepts I
Room: Van Horne Ballroom C

Speaker 4 of 6
James E. Robinson, Tulane University Health Sciences Center, USA
Probing the Neutralization Face of HIV-1 Env with Human Monoclonal Antibodies

Tuesday, April 12 | 8:00AM - 11:00AM
Novel Immunogens and Vaccine Concepts I
Room: Van Horne Ballroom C

Speaker 5 of 6
Robert G. Whalen, Altravax, Inc., USA
Short Talk: Use of Directed Molecular Evolution to Create Novel HIV-1 Envelope Variants Capable of Inducing Broadly Neutralizing Antibody Responses in Rabbits

Tuesday, April 12 | 8:00AM - 11:00AM
Novel Immunogens and Vaccine Concepts I
Room: Van Horne Ballroom C

Speaker 6 of 6
Dan H. Barouch, Beth Israel Deaconess Medical Center, USA
Short Talk: Antigen- and Vector-Specific Immune Responses Elicited by rAd5, rAd35, and Chimeric rAd35k5 Vaccines for HIV/SIV in Rhesus Monkeys

Tuesday, April 12 | 8:00AM - 11:15AM
Pathogenesis: Determinants of Disease Progression. Session
Sponsored in Part by Gilead Sciences, Inc.
This session is from HIV Pathogenesis

Room: Van Horne Ballroom AB

Speaker 1 of 6
* Michael M. Lederman, Case Western Reserve University, USA


Tuesday, April 12 | 8:00AM - 11:15AM
Pathogenesis: Determinants of Disease Progression. Session
Sponsored in Part by Gilead Sciences, Inc.
This session is from HIV Pathogenesis

Room: Van Horne Ballroom AB

Speaker 2 of 6
Julie M. Overbaugh, Fred Hutchinson Cancer Research Center, USA
Studies HIV-1 Acquisition in the Absence and Presence of Existing Infection


Tuesday, April 12 | 8:00AM - 11:15AM
Pathogenesis: Determinants of Disease Progression. Session
Sponsored in Part by Gilead Sciences, Inc.
This session is from HIV Pathogenesis

Room: Van Horne Ballroom AB

Speaker 3 of 6
Mary Carrington, NCI, National Institutes of Health, USA
The Influence of HLA on HIV: Relating Allelic Effects in Disease Progression to Those in Infection


Tuesday, April 12 | 8:00AM - 11:15AM
Pathogenesis: Determinants of Disease Progression. Session
Sponsored in Part by Gilead Sciences, Inc.
This session is from HIV Pathogenesis

Room: Van Horne Ballroom AB

Speaker 4 of 6
Steven G. Deeks, University of California, San Francisco, USA
Immune Activation, Viral Fitness and Disease Progression


Tuesday, April 12 | 8:00AM - 11:15AM
Pathogenesis: Determinants of Disease Progression. Session
Sponsored in Part by Gilead Sciences, Inc.
This session is from HIV Pathogenesis

Room: Van Horne Ballroom AB

Speaker 5 of 6
Mark B. Feinberg, IAVI International AIDS Vaccine Initiative, USA
Lessons from Sooty Mangabeys


Tuesday, April 12 | 8:00AM - 11:15AM
Pathogenesis: Determinants of Disease Progression. Session
Sponsored in Part by Gilead Sciences, Inc.
This session is from HIV Pathogenesis

Room: Van Horne Ballroom AB

Speaker 6 of 6
Bruce D. Walker, Ragon Institute of MGH, MIT and Harvard, USA
Immunology and Virology of Controlled HIV Infection


Tuesday, April 12 | 9:20AM - 9:40AM
Coffee Break
Room: Van Horne Ballroom Foyer


Tuesday, April 12 | 11:00AM - 1:00PM
Poster Setup
Room: New Brunswick, Alberta, Cascade


Tuesday, April 12 | 1:00PM - 10:00PM
Poster Viewing
Room: New Brunswick, Alberta, Cascade


Tuesday, April 12 | 2:30PM - 4:30PM
Workshkop 2: Immune Pathogenesis
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 1 of 7
* Irini Sereti, NIAID, National Institutes of Health, USA


Tuesday, April 12 | 2:30PM - 4:30PM
Workshkop 2: Immune Pathogenesis
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 2 of 7
Arnaud Moris, INSERM - CNRS - UPMC - Hôpital Pitié-Salpêtrière, France
HIV-1 Antigen Presentation by DCs: Role of DC-SIGN


Tuesday, April 12 | 2:30PM - 4:30PM
Workshkop 2: Immune Pathogenesis
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 3 of 7
Karin Loré, Karolinska Institutet, Sweden
Productively Infected Myeloid and Plasmacytoid Dendritic Cells Transfer of HIV-1 Preferentially to Antigen-Specific CD4+ T-Cells


Tuesday, April 12 | 2:30PM - 4:30PM
Workshkop 2: Immune Pathogenesis
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 4 of 7
Jean Philippe Herbeuval, National Cancer Institute, National Institutes of Health, USA
AIDS Pathogenesis: Effect of HAART on TRAIL/DR5 Mediated CD4+ T Cell Apoptosis


Tuesday, April 12 | 2:30PM - 4:30PM
Workshkop 2: Immune Pathogenesis
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 5 of 7
Scott F. Sieg, Case Western Reserve University, USA
Circulating S Phase T Cells from HIV-Infected Persons are Prone to Die, Express Low Levels of bcl-2 and are Rescued from Apoptosis by Interleukin-2


Tuesday, April 12 | 2:30PM - 4:30PM
Workshkop 2: Immune Pathogenesis
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 6 of 7
Michael R. Betts, University of Pennsylvania, USA
HIV-Infected Long-Term Nonprogressors Maintain Polyfunctional HIV Specific CD8+ T Cell Responses of Diverse Memory Phenotypes


Tuesday, April 12 | 2:30PM - 4:30PM
Workshkop 2: Immune Pathogenesis
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 7 of 7
Emma L. Turnbull, Jenner Institute, University of Oxford, UK
Analysis of the Functional Cross-Reactivity and Clonality of HIV-Specific CD8+ T Cells Restricted by HLA Alleles Associated with Differing Rates of Progression to AIDS


Tuesday, April 12 | 4:30PM - 5:00PM
Coffee & Snacks Available
Room: Van Horne Ballroom Foyer


Tuesday, April 12 | 5:00PM - 7:00PM
Novel Immunogens and Vaccine Concepts II
Room: Van Horne Ballroom C

Speaker 1 of 3
Peter D. Kwong, NIAID, National Institutes of Health, USA
Crystallographic Approach to Vaccine Design Based on the Antigenic and Atomic Structure of Env

Tuesday, April 12 | 5:00PM - 7:00PM
Novel Immunogens and Vaccine Concepts II
Room: Van Horne Ballroom C

Speaker 2 of 3
Andrew J. McMichael, Oxford University, UK
A Boost for MVA

Tuesday, April 12 | 5:00PM - 7:00PM
Novel Immunogens and Vaccine Concepts II
Room: Van Horne Ballroom C

Speaker 3 of 3
* Philip R. Johnson, Children's Hospital of Philadelphia, USA
rAAV Vectors as Novel HIV Vaccines

Tuesday, April 12 | 5:00PM - 7:00PM
Late Breaking Developments
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 1 of 8
* Joseph (Mike) McCune, Bill & Melinda Gates Foundation, USA


Tuesday, April 12 | 5:00PM - 7:00PM
Late Breaking Developments
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 2 of 8
* Richard A. Koup, NIAID, National Institutes of Health, USA


Tuesday, April 12 | 5:00PM - 7:00PM
Late Breaking Developments
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 3 of 8
Cristian Apetrei, University of Pittsburgh, USA
Short Talk: SIVsm Derived from Naturally Infected Sooty Mangabeys Is Not Intrinsically Highly Pathogenic for Rhesus Macaques


Tuesday, April 12 | 5:00PM - 7:00PM
Late Breaking Developments
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 4 of 8
Alfredo Garzino-Demo, University of Maryland School of Medicine, USA
Short Talk: Insights in the Mechanism of HIV Suppression by beta-Defensins


Tuesday, April 12 | 5:00PM - 7:00PM
Late Breaking Developments
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 5 of 8
Sara R. Klucking, Emory University, USA
Short Talk: Functional Differences in Dendritic Cell Populations and Divergent Disease Outcomes in Primate Models of HIV Infection


Tuesday, April 12 | 5:00PM - 7:00PM
Late Breaking Developments
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 6 of 8
Catherine S. Adamson, National Cancer Institute, National Institutes of Health, USA
Short Talk: Viral Resistance to PA-457, a Novel Inhibitor of HIV-1 Maturation: Insights in to the Drug Target and Mechanisms of Action


Tuesday, April 12 | 5:00PM - 7:00PM
Late Breaking Developments
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 7 of 8
Joseph Mattapallil, Uniformed Services University of the Health Sciences, USA
Short Talk: Massive Infection and Loss of Memory CD4 T-cells in peripheral and mucosal Tissues During Acute SIV Infection


Tuesday, April 12 | 5:00PM - 7:00PM
Late Breaking Developments
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 8 of 8
Alexandra Trkola, University of Zürich, Switzerland
Short Talk: Delay of HIV-1 Rebound after Cessation of Antiretroviral Therapy through Passive Administration of Human Neutralizing Antibodies


Tuesday, April 12 | 7:00PM - 8:00PM
Social Hour
Room: New Brunswick, Alberta, Cascade


Tuesday, April 12 | 7:30PM - 10:00PM
Poster Session 3
Room: New Brunswick, Alberta, Cascade


Wednesday, April 13 | 7:00AM - 8:00AM
Breakfast
Room: New Brunswick, Alberta, Cascade


Wednesday, April 13 | 8:00AM - 11:00AM
CD8 Cell Function and Dysfunction (Joint)
Room: Van Horne Ballroom

Speaker 1 of 7
* Marcus Altfeld, Heinrich-Pette-Institute, Germany

Wednesday, April 13 | 8:00AM - 11:00AM
CD8 Cell Function and Dysfunction (Joint)
Room: Van Horne Ballroom

Speaker 2 of 7
Giuseppe Pantaleo, Centre Hospitalier Universitaire Vaudois, Switzerland
Functional Signatures of Protective Memory T-Cell Responses

Wednesday, April 13 | 8:00AM - 11:00AM
CD8 Cell Function and Dysfunction (Joint)
Room: Van Horne Ballroom

Speaker 3 of 7
Richard A. Koup, NIAID, National Institutes of Health, USA
CD8 and CD4 Cel Function in Viral Infection and Vaccintations

Wednesday, April 13 | 8:00AM - 11:00AM
CD8 Cell Function and Dysfunction (Joint)
Room: Van Horne Ballroom

Speaker 4 of 7
Joseph (Mike) McCune, Bill & Melinda Gates Foundation, USA
HIV-Induced Perturbations of CD8+ T Cell Maturation


Wednesday, April 13 | 8:00AM - 11:00AM
CD8 Cell Function and Dysfunction (Joint)
Room: Van Horne Ballroom

Speaker 5 of 7
Annika C. Karlsson, Karolinska Institutet, Sweden
Short Talk: Diversity of Epitope and Cytokine Profiles at Different Stages of HIV-1 Infection

Wednesday, April 13 | 8:00AM - 11:00AM
CD8 Cell Function and Dysfunction (Joint)
Room: Van Horne Ballroom

Speaker 6 of 7
Sylvie Le Gall, Massachusetts General Hospital, Harvard Medical School, USA
Short Talk: Contribution of Antigen Processing to the Immunodominance of an HLA-A3-Restricted HIV Epitope

Wednesday, April 13 | 8:00AM - 11:00AM
CD8 Cell Function and Dysfunction (Joint)
Room: Van Horne Ballroom

Speaker 7 of 7
Astrid K.N. Iversen, Weatherall Institute of Molecular Medicine, UK
Short Talk: The Effect of Common Amino Acid Mutations in Overlapping HIV-1 p17 Gag CTL Epitopes on HLA Binding and Cytotoxic T-Cell Responses

Wednesday, April 13 | 9:20AM - 9:40AM
Coffee Break
Room: Van Horne Ballroom Foyer


Wednesday, April 13 | 11:00AM - 1:00PM
Poster Setup
Room: New Brunswick, Alberta, Cascade


Wednesday, April 13 | 1:00PM - 10:00PM
Poster Viewing
Room: New Brunswick, Alberta, Cascade


Wednesday, April 13 | 2:30PM - 4:30PM
Workshop 2: Mucosal Immunity
Room: Van Horne Ballroom C

Speaker 1 of 5
* Jiri Mestecky, University of Alabama at Birmingham, USA
Mucosal Immune Responses to HIV in the Genital Tract of Infected, Highly Exposed Sero-negative, or Immunized Individuals

Wednesday, April 13 | 2:30PM - 4:30PM
Workshop 2: Mucosal Immunity
Room: Van Horne Ballroom C

Speaker 2 of 5
Robert W. Coombs, University of Washington, USA
Mucosal Shedding of HIV-1: Potential for Interference by Immune Responses

Wednesday, April 13 | 2:30PM - 4:30PM
Workshop 2: Mucosal Immunity
Room: Van Horne Ballroom C

Speaker 3 of 5
Ronald S. Veazey, Tulane National Primate Research Center, USA
Mucosal Cellular Responses in Nonhuman Primate Models of SIV

Wednesday, April 13 | 2:30PM - 4:30PM
Workshop 2: Mucosal Immunity
Room: Van Horne Ballroom C

Speaker 4 of 5
Igor M. Belyakov, National Cancer Institute, National Institutes of Health, USA
Short Talk: Mucosal Prime-Boost AIDS Vaccine Induces High Avidity CD8+ CTL Response and Delays Viremia After Intrarectal Infection of Macaques

Wednesday, April 13 | 2:30PM - 4:30PM
Workshop 2: Mucosal Immunity
Room: Van Horne Ballroom C

Speaker 5 of 5
Shehzad Iqbal, University of Toronto, Canada
Short Talk: Characterization of the Genital Mucosa of HIV Resistant Sex Workers Reveal Increased CD4+ T Cells, RANTES Levels and a Number of Potential Biomarkers by Proteomics Analysis

Wednesday, April 13 | 4:30PM - 5:00PM
Coffee & Snacks Available
Room: Van Horne Ballroom Foyer


Wednesday, April 13 | 5:00PM - 7:15PM
Animal Models I
Room: Van Horne Ballroom C

Speaker 1 of 5
* Norman L. Letvin, Beth Israel Deaconess Medical Center, USA
Nonhuman Primate HIV Vaccine Studies: Will They be Predictive?

Wednesday, April 13 | 5:00PM - 7:15PM
Animal Models I
Room: Van Horne Ballroom C

Speaker 2 of 5
Marjorie Robert-Guroff, NCI, National Institutes of Health, USA
A Role for Replication-Competent Adenovirus Recombinants in Vaccine Design

Wednesday, April 13 | 5:00PM - 7:15PM
Animal Models I
Room: Van Horne Ballroom C

Speaker 3 of 5
Mauro Bendinelli, Universita di Pisa, Italy
Are there lessons that can be learned from the FIV model?

Wednesday, April 13 | 5:00PM - 7:15PM
Animal Models I
Room: Van Horne Ballroom C

Speaker 4 of 5
Cristian Apetrei, University of Pittsburgh, USA
Short Talk: Molecular Epidemiology of SIVsm in Primate Centers in the United States over a 30 Year Period. Consequences for Diagnostic and Monitoring of SIVsm Infection

Wednesday, April 13 | 5:00PM - 7:15PM
Animal Models I
Room: Van Horne Ballroom C

Speaker 5 of 5
Salvatore T. Butera, Centers for Disease Control and Prevention, USA
Short Talk: Application of Repeated Mucosal Virus Exposures in Non-Human Primates to Evaluate Strategies to Prevent HIV-1 Transmission

Wednesday, April 13 | 5:00PM - 7:30PM
Innate Host Defenses
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 1 of 6
* Donald E. Mosier, The Scripps Research Institute, USA


Wednesday, April 13 | 5:00PM - 7:30PM
Innate Host Defenses
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 2 of 6
Robert H. Silverman, Cleveland Clinic Foundation, USA
Interferon Antiviral Defenses Mediated by the 2-5A/RNase L Pathway


Wednesday, April 13 | 5:00PM - 7:30PM
Innate Host Defenses
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 3 of 6
Aaron Weinberg, Case Western Reserve University, USA
Mucosal Antiviral beta Defensins


Wednesday, April 13 | 5:00PM - 7:30PM
Innate Host Defenses
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 4 of 6
Greg J. Towers, University College London, UK
Restriction of Retroviral Infection by TRIM5


Wednesday, April 13 | 5:00PM - 7:30PM
Innate Host Defenses
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 5 of 6
Michael H. Malim, King's College London, UK
APOBEC Proteins, Cytidine Deamination and Innate Resistance to HIV Infection


Wednesday, April 13 | 5:00PM - 7:30PM
Innate Host Defenses
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 6 of 6
Olivier Schwartz, Institut Pasteur, France
Short Talk: APOBEC3G: An Ancestral Wide Cellular Defence Against Endogenous and Exogenous Retroviruses


Wednesday, April 13 | 7:15PM - 8:15PM
Social Hour
Room: New Brunswick, Alberta, Cascade


Wednesday, April 13 | 7:30PM - 10:00PM
Poster Session 4
Room: New Brunswick, Alberta, Cascade


Thursday, April 14 | 7:00AM - 8:00AM
Breakfast
Room: New Brunswick, Alberta, Cascade


Thursday, April 14 | 8:00AM - 11:00AM
Animal Models II
Room: Van Horne Ballroom C

Speaker 1 of 6
* Anna Aldovini, Boston Children's Hospital and Harvard Medical School, USA
Control of SHIV Viremia and Disease Progression after DNA-MVA Mucosal Immunization in Macaques

Thursday, April 14 | 8:00AM - 11:00AM
Animal Models II
Room: Van Horne Ballroom C

Speaker 2 of 6
James A. Hoxie, University of Pennsylvania, USA
Modulation of SIVmac Pathogenicity and Host Immune Responses by Mutations in the Envelope Transmembrane Cytoplasmic Tail

Thursday, April 14 | 8:00AM - 11:00AM
Animal Models II
Room: Van Horne Ballroom C

Speaker 3 of 6
Ruth M. Ruprecht, Texas Biomedical Research Institute, USA
Harnessing the Power of Monoclonal Antibody Combinations

Thursday, April 14 | 8:00AM - 11:00AM
Animal Models II
Room: Van Horne Ballroom C

Speaker 4 of 6
Vanessa M. Hirsch, NIAID, National Institutes of Health, USA
Virologic Features of Pathogenic and Natural Infection with Simian Immunodeficiency Viruses

Thursday, April 14 | 8:00AM - 11:00AM
Animal Models II
Room: Van Horne Ballroom C

Speaker 5 of 6
John K. Rose, Yale University School of Medicine, USA
Short Talk: Protection Against SIVmac251 Challenge in Rhesus Macaques Vaccinated with VSV and MVA Vectors Expressing Seven SIV Genes

Thursday, April 14 | 8:00AM - 11:00AM
Animal Models II
Room: Van Horne Ballroom C

Speaker 6 of 6
Jeffrey D. Lifson, Leidos Biomedical Research, Inc., USA
Short Talk: Working Backwards to a Vaccine for Control of AIDS Virus Infection

Thursday, April 14 | 8:00AM - 11:15AM
Latency and Activation
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 1 of 7
* Frederic D. Bushman, University of Pennsylvania, USA


Thursday, April 14 | 8:00AM - 11:15AM
Latency and Activation
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 2 of 7
Jerome A. Zack, University of California, Los Angeles, USA
Modeling HIV Latency


Thursday, April 14 | 8:00AM - 11:15AM
Latency and Activation
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 3 of 7
Gary J. Nabel, Sanofi, USA
The Gene Product Murr1 Restricts HIV-1 Replication in Resting CD4+ Lymphocytes


Thursday, April 14 | 8:00AM - 11:15AM
Latency and Activation
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 4 of 7
Jonathan Karn, Case Western Reserve University, USA
NF-kappaB and CBF-1: Specific Activators and Repressors of HIV Transcription


Thursday, April 14 | 8:00AM - 11:15AM
Latency and Activation
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 5 of 7
Mario Stevenson, University of Miami, Leonard M. Miller School of Medicine, USA
Cellular Factors that Influence Virus-Host Cell Interplay


Thursday, April 14 | 8:00AM - 11:15AM
Latency and Activation
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 6 of 7
Roger J. Pomerantz, Seres Therapeutics, Inc., USA
Short Talk: IL-7 Potently and Strain-Specifically Induces the Latent HIV-1 Reservoirs


Thursday, April 14 | 8:00AM - 11:15AM
Latency and Activation
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 7 of 7
Nancie M. Archin, University of North Carolina at Chapel Hill, USA
Short Talk: Chromatin Deacetylation does not Precede Waning of HIV Expression


Thursday, April 14 | 9:20AM - 9:40AM
Coffee Break
Room: Van Horne Ballroom Foyer


Thursday, April 14 | 2:30PM - 4:30PM
Workshop 3: Novel Adjuvants
Room: Van Horne Ballroom C

Speaker 1 of 7
* Jorge E. Flores, PATH, USA

Thursday, April 14 | 2:30PM - 4:30PM
Workshop 3: Novel Adjuvants
Room: Van Horne Ballroom C

Speaker 2 of 7
Qigui Yu, Canada
Expansion of HIV-1-Specific Memory CTL Responses by Dendritic Cells Infected with Human CD154 (CD40L)-Expressing ALVAC Virus: Towards the Development of Molecular Adjuvants for HIV-1 Vaccines

Thursday, April 14 | 2:30PM - 4:30PM
Workshop 3: Novel Adjuvants
Room: Van Horne Ballroom C

Speaker 3 of 7
Richard S. Kornbluth, Multimeric Biotherapeutics, Inc., USA
Multimeric Soluble CD40 Ligand and GITR Ligand as DNA Vaccine Adjuvants

Thursday, April 14 | 2:30PM - 4:30PM
Workshop 3: Novel Adjuvants
Room: Van Horne Ballroom C

Speaker 4 of 7
John P. Moore, Weill Medical College of Cornell University, USA
The Use of Topically Applied Imiquimod to Induce T-Helper Responses to HIV-1 Env Glycoproteins

Thursday, April 14 | 2:30PM - 4:30PM
Workshop 3: Novel Adjuvants
Room: Van Horne Ballroom C

Speaker 5 of 7
Abdul M. Jabbar, Emory University, USA
Augmenting Immunogenicity of DNA Vaccines: Role of Plasmid-Encoded Flt-3 Ligand, as a Molecular Adjuvant in Genetic Vaccination

Thursday, April 14 | 2:30PM - 4:30PM
Workshop 3: Novel Adjuvants
Room: Van Horne Ballroom C

Speaker 6 of 7
John R. Greenland, Harvard Medical School, USA
Beta-Amino Ester Polymers Facilitate in vivo DNA Transfection and Adjuvant Plasmid DNA Immunization

Thursday, April 14 | 2:30PM - 4:30PM
Workshop 3: Novel Adjuvants
Room: Van Horne Ballroom C

Speaker 7 of 7
Andreas Bråve, Karolinska Institute, Sweden
Needle Free Intradermal Delivery of a Multi-Gene/Multi-Subtype HIV-1 Vaccine with Recombinant GM-CSF

Thursday, April 14 | 4:30PM - 5:00PM
Coffee & Snacks Available
Room: Van Horne Ballroom Foyer


Thursday, April 14 | 5:00PM - 7:00PM
Clinical HIV Vaccine Trials
Room: Van Horne Ballroom C

Speaker 1 of 3
* Barney S. Graham, NIAID, National Institutes of Health, USA
Update on VRC Clinical Trials of Multi-Clade DNA and rAd5 Vaccines

Thursday, April 14 | 5:00PM - 7:00PM
Clinical HIV Vaccine Trials
Room: Van Horne Ballroom C

Speaker 2 of 3
John W. Shiver, Sanofi Pasteur, USA
Development of an HIV-1 Vaccine Based on Replication-Defective Adenovirus Vectors

Thursday, April 14 | 5:00PM - 7:00PM
Clinical HIV Vaccine Trials
Room: Van Horne Ballroom C

Speaker 3 of 3
Jorge E. Flores, PATH, USA
The HIV-1 Vaccine Pipeline and Global Expansion of Clinical Trials

Thursday, April 14 | 5:00PM - 6:45PM
Immune Defense and Pathogenesis
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 1 of 5
* Gene M. Shearer, National Cancer Institute, National Institutes of Health, USA


Thursday, April 14 | 5:00PM - 6:45PM
Immune Defense and Pathogenesis
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 2 of 5
Rafick Sekaly, Case Western Reserve University, USA
Genomic Profiling of Memory T Cell Population in Healthy and HIV Patients


Thursday, April 14 | 5:00PM - 6:45PM
Immune Defense and Pathogenesis
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 3 of 5
Daniel C. Douek, NIAID, National Institutes of Health, USA
T-Cell Receptor Recognition Motifs and Immune Escape in Acute SIV Infection


Thursday, April 14 | 5:00PM - 6:45PM
Immune Defense and Pathogenesis
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 4 of 5
Fatema A. Legrand, University of California, San Francisco, USA
Short Talk: Divergent Immune Responses in HIV-1 Vertically
Infected Monozygotic Twins


Thursday, April 14 | 5:00PM - 6:45PM
Immune Defense and Pathogenesis
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 5 of 5
Guillaume B.E. Stewart-Jones, National Institutes of Health, USA
Short Talk: Crystal Structures of HIV-1 HLA-B*5703-Peptide Complexes and Identification of Related HLA Motifs


Thursday, April 14 | 6:45PM - 7:00PM
Closing Remarks
This session is from HIV Pathogenesis
Room: Van Horne Ballroom AB

Speaker 1 of 1
Michael M. Lederman, Case Western Reserve University, USA


Thursday, April 14 | 7:00PM - 8:00PM
Social Hour
Room: New Brunswick, Alberta, Riverview


Thursday, April 14 | 8:00PM - 11:00PM
Entertainment
Room: New Brunswick, Alberta, Riverview


Thursday, April 14 | 8:00PM - 11:00PM
Cash Bar
Room: New Brunswick, Alberta, Riverview


Friday, April 15 | 10:21AM - 10:21AM
Departure


*Session Chair
†Invited, not yet responded.